Alexandria Real Estate Equities, Inc., at the Vanguard of Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand from the Life Science Industry, Reports: 2Q21 and 1H21 Net Income per Share - Diluted of $2.61 and $2.74, respectively; 2Q21 and 1H21 FFO per Share - Diluted, As Adjusted, of $1.93 and $3.84, respectively

Rhea-AI Summary

On July 26, 2021, Alexandria Real Estate Equities (ARE) reported strong financial results for Q2 2021. Total revenues increased by 16.6% to $509.6 million, and net income attributable to common stockholders rose to $380.6 million, up from $226.6 million YoY. The company enjoyed historic leasing activity, with 1.9 million RSF leased and rental rate increases of 42.4%. A strong balance sheet was highlighted with $4.5 billion in liquidity, and tenant collections reached 99.4%. Alexandria continues its strategic growth, focusing on life sciences with significant ongoing and future development projects.

Positive

• Total revenues increased by 16.6% year-over-year to $509.6 million.
• Net income attributable to common stockholders rose to $380.6 million, compared to $226.6 million YoY.
• Historic leasing activity of 1.9 million RSF, the highest in a single quarter.
• 42.4% rental rate increase during Q2 2021.
• Strong liquidity position with $4.5 billion available as of June 30, 2021.
• Tenant collections at 99.4% for July 2021, the lowest receivables since 2012.

Negative

• None.

PASADENA, Calif., July 26, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the second quarter ended June 30, 2021.

Key highlights
Operating results				2Q21			2Q20			1H21			1H20
Total revenues:
In millions				$	509.6		$	437.0		$	989.5		$	876.9
Growth				16.6%							12.8%
Net income attributable to Alexandria's common stockholders – diluted
In millions				$	380.6		$	226.6		$	388.5		$	244.8
Per share				$	2.61		$	1.82		$	2.74		$	1.99
Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted
In millions				$	282.3		$	225.0		$	545.2		$	446.4
Per share				$	1.93		$	1.81		$	3.84		$	3.63

Six-time Nareit Investor CARE Gold Award winner

2021 recipient of the Nareit Investor CARE (Communications and Reporting Excellence) Gold Award in the Large Cap Equity REIT category as the best-in-class REIT delivering transparency, quality, and efficient communications and reporting to the investment community. This represents our fourth consecutive Nareit Investor CARE Gold Award, and our sixth Gold Award over the last seven years.

Historic leasing activity and rental rate growth; continued strong net operating income and internal growth

• During 2Q21, historic demand for our high-quality office/laboratory space translated into 1.9 million RSF of leasing activity, representing the highest leasing activity in a single quarter and the second highest rental rate growth in Company history.
• Continued strong leasing activity and rental rate growth during 2Q21 and 1H21 over expiring rates on renewed and re-leased space:

		2Q21			1H21
Total leasing activity – RSF		1,933,838			3,611,497
Leasing of development and redevelopment space – RSF		256,328			1,045,301
Lease renewals and re-leasing of space:
RSF (included in total leasing activity above)		1,472,713			1,994,538
Rental rate increases		42.4%			40.7%
Rental rate increases (cash basis)		25.4%			23.3%

• Net operating income (cash basis) of $1.3 billion for 2Q21 annualized, up $194.4 million, or 17.6%, compared to 2Q20 annualized.
• 95% of our leases contain contractual annual rent escalations approximating 3%.
• Same property net operating income growth:
• 3.7% and 7.8% (cash basis) for 2Q21 over 2Q20.
• 4.4% and 7.4% (cash basis) for 1H21 over 1H20.

A REIT industry-leading high-quality tenant roster with high-quality revenues and cash flows, strong margins, and operational excellence

Percentage of annual rental revenue in effect from investment-grade or       publicly traded large cap tenants		53%
Occupancy of operating properties in North America		94.3%		(1)
Operating margin		72%
Adjusted EBITDA margin		69%
Weighted-average remaining lease term:
All tenants		7.5		years
Top 20 tenants		11.1		years

(1)

Includes 1.4 million RSF, or 3.8%, of vacancy at recently acquired properties in our North America markets, representing lease-up opportunities that are expected to provide incremental annual rental revenues in excess of $55 million. Approximately 35% of the vacant 1.4 million RSF is currently under leased/negotiating, with occupancy expected primarily over the next two quarters. Excluding these acquired vacancies, occupancy of operating properties in North America was 98.1% as of June 30, 2021. Refer to "Occupancy" of our Supplemental Information for additional details.

Strong and flexible balance sheet with significant liquidity

• Investment-grade credit ratings ranked in the top 10% among all publicly traded U.S. REITs as of June 30, 2021.
• Net debt and preferred stock to Adjusted EBITDA of 5.8x for 2Q21 annualized.
• Fixed-charge coverage ratio of 4.9x for 2Q21 annualized.
• $4.5 billion of liquidity as of June 30, 2021.

Continued dividend strategy to share growth in cash flows with stockholders

Common stock dividend declared for 2Q21 of $1.12 per common share, aggregating $4.36 per common share for the twelve months ended June 30, 2021, up 24 cents, or 6%, over the twelve months ended June 30, 2020. Our FFO payout ratio of 60% for the three months ended June 30, 2021, allows us to continue to share growth in cash flows from operating activities with our stockholders while also retaining a significant portion for reinvestment. 

Sustained strength in tenant collections

• Tenant collections remain consistently high, with 99.4% of July 2021 billings collected as of the date of this release.
• As of June 30, 2021, our tenant receivables balance was $6.7 million, representing our lowest balance since 2012.

Leasing activity of development and redevelopment projects

We continue to execute our unique and differentiated life science strategy at an accelerated pace and expand our collaborative campuses and asset base in each of our key life science cluster submarkets, and we remain strategically positioned to take maximum advantage of historic tenant demand. Demand for our value-creation development and redevelopment projects of high-quality office/laboratory space, as well as continued operational excellence at our world-class, sophisticated laboratory facilities and strong execution by our team, has translated into record leasing activity. The following table provides leasing activity of our development and redevelopment projects:

Leased RSF

In-Process RSF(1)

2020

1H21

As of July 26, 2021

1.0 million

1.0 million

3.0 million

(1)	Represents in-process leasing activity on near-term value-creation development and redevelopment projects that are expected to commence vertical construction in 2021/2022. Includes 2.2 million RSF related to leases under negotiation/executed letters of intent and 0.8 million RSF related to letters of intent under negotiation.

Value-creation development and redevelopment projects are expected to generate significant growth in rental revenues and cash flows

Under Construction			Projects Expected to Commence Construction in 2021/2022			Incremental Projected Annual Rental Revenues
3.4 million RSF			3.6 million RSF			>$545 million
33 Properties	+		19 Properties	=
80% Leased/Negotiating			89% Leased/Negotiating

Delivery of fully leased value-creation projects

• During 2Q21, we placed into service development and redevelopment projects aggregating 755,565 RSF that are 100% leased across five submarkets.
• Annual net operating income (cash basis) is expected to increase by $49 million upon the burn-off of initial free rent from recently delivered projects.

Key items included in operating results

Key items included in net income attributable to Alexandria's common stockholders:
(In millions, except per share amounts)	Amount						Per Share – Diluted						Amount						Per Share – Diluted
	2Q21			2Q20			2Q21			2Q20			1H21			1H20			1H21			1H20
Unrealized gains on non-real estate investments	$	244.0		$	171.7		$	1.67		$	1.38		$	197.8		$	154.5		$	1.39		$	1.25
Realized gains on non-real estate investments	34.8		(1)	—			0.24			—			57.7			—			0.41			—
Gain on sales of real estate	—			—			—			—			2.8			—			0.02			—
Impairment of real estate	(4.9)			(13.2)			(0.03)			(0.11)			(10.1)			(22.9)			(0.07)			(0.18)
Impairment of non-real estate investments	—			(4.7)			—			(0.04)			—			(24.5)			—			(0.20)
Loss on early extinguishment of debt	—			—			—			—			(67.3)			—			(0.47)			—
Total	$	273.9		$	153.8		$	1.88		$	1.23		$	180.9		$	107.1		$	1.28		$	0.87

(1)	Refer to "Funds from operations and funds from operations per share" of this Earnings Press Release for additional details.

Alexandria at the vanguard of innovation for over 750 tenants and looking to accommodate current needs plus a path for future growth

• In June 2021, we entered into a definitive agreement to expand our Alexandria Center^® at Kendall Square campus through our acquisition of a 100% interest in One Rogers Street and One Charles Park for a purchase price of $815.0 million. This acquisition provides a key expansion to our mega campus strategy in our Cambridge submarket, the premier life science real estate market in the world, and consists of the following:
• Upon closing of the acquisition, we expect to redevelop the two existing buildings, along with the services of The Davis Companies, into a Class A life science project aggregating 400,000 RSF of technical office/laboratory space. We will retain our wholly owned interest in the project upon completion of the redevelopments.
• These two buildings are 100% under lease negotiation with several cutting-edge life science companies.
• The redevelopment project is targeting initial occupancy in 2023.
• Parking garage with approximately 650 spaces.
• We expect to pursue additional entitlement opportunities for future development of additional office/laboratory space at this site.
• We expect to complete this acquisition in December 2021.
• During 2Q21, we completed acquisitions in our key life science cluster submarkets aggregating 5.5 million SF (includes Sequence Drive described in the next bullet); 4.7 million RSF of value-creation opportunities; and 0.9 million RSF of operating space, for an aggregate purchase price of $1.1 billion.
• In June 2021, we acquired five operating buildings at 6260, 6290, 6310, 6340, and 6350 Sequence Drive aggregating 487,023 RSF, located in our Sorrento Mesa submarket, for a purchase price of $298.5 million, with opportunity to increase the campus by approximately 400,000 SF through ground-up development.
• The five operating buildings are currently 100% occupied with a weighted-average remaining lease term of 2.7 years. We expect to develop or redevelop these spaces upon expiration of the existing in-place leases.
• The aggregate 887,000 RSF from this acquisition provides a significant future development opportunity to expand our existing Sequence District by Alexandria campus into a flagship mega campus aggregating 1.9 million SF.

Key strategic transactions that generated capital for investment into our highly leased value-creation pipeline and acquisitions with development and redevelopment opportunities

• In April 2021, we sold a 70% partial interest in our 213 East Grand Avenue property located in our South San Francisco submarket for a sales price of $301.0 million, or $1,429 per RSF, representing capitalization rates of 4.5% and 4.0% (cash basis).
• In July 2021, we sold a 70% partial interest in our 400 Dexter Avenue North property located in our Lake Union submarket for a sales price of $254.8 million, or $1,255 per RSF, representing capitalization rates of 4.1% and 4.2% (cash basis).

Balance sheet management

Key metrics as of June 30, 2021

• $36.3 billion of total market capitalization.
• $27.4 billion of total equity capitalization.
• No debt maturities prior to 2024.
• 12.5 years weighted-average remaining term of debt as of June 30, 2021.
• Investment-grade credit ratings ranked in the top 10% among all publicly traded U.S. REITs as of June 30, 2021.

		2Q21					Goal
		Quarter			Trailing		4Q21
		Annualized			12 Months		Annualized
Net debt and preferred stock to       Adjusted EBITDA		5.8x			6.2x		Less than or equal to 5.2x
Fixed-charge coverage ratio		4.9x			4.6x		Greater than or equal to 5.0x

 

Value-creation pipeline of new Class A development and redevelopment projects as a percentage of gross investments in real estate		2Q21
Current and key near-term projects and key pending acquisition 84% leased/negotiating		10%
Income-producing/potential cash flows/covered land play(1)		6%
Land		2%

(1)	Includes projects that have existing buildings that are generating or can generate operating cash flows. Also includes development rights associated with existing operating campuses.

Key capital events

• In June 2021, we entered into forward equity sales agreements aggregating $1.5 billion to sell 8.1 million shares of our common stock (including the exercise of underwriters' option) at a public offering price of $184.00 per share, before underwriting discounts and commissions.
• In 2Q21, we settled a portion of these forward equity sales agreements by issuing 4.9 million shares and received net proceeds of $870.3 million.
• We expect to issue 3.1 million shares in 2H21 to settle our remaining outstanding forward equity sales agreements and receive net proceeds of approximately $547.8 million.
• We also expect to issue 1.5 million shares in 2H21 to settle our remaining outstanding January 2021 forward equity sales agreements and receive net proceeds of approximately $230.5 million.
• During 2Q21, there was no sale activity under our ATM common stock offering program. As of July 26, 2021, the remaining aggregate amount available under our current program for future sales of common stock is $500.0 million.

Investments

• As of June 30, 2021, our investments aggregated $2.0 billion, including an adjusted cost basis of $1.0 billion, unrealized gains of $1.0 billion, and $48.0 million of investments accounted for under the equity method of accounting.
• Investment income of $304.3 million for 2Q21 included $60.2 million in realized gains and $244.0 million in unrealized gains.

Subsequent events

• In July 2021, we completed acquisitions for an aggregate purchase price of $387.9 million, comprising 496,070 RSF of operating properties with future development and redevelopment opportunities and 335,825 RSF of operating properties strategically located across multiple markets.

Industry and ESG leadership: catalyzing and leading the way for positive change to benefit human health and society

Industry leadership

• We were ranked in the top 10 of the world's largest and most impactful real estate firms on the Forbes 2021 Global 2000 list determined based on sales, profits, assets, and market value.
• In June 2021, we released our 2020 Environmental, Social & Governance Report, which showcases our longstanding ESG commitment and leadership. Key highlights in the report include the company's critical efforts to tackle climate change by pioneering low-carbon and climate-resilient design solutions (refer to page iii for spotlight on 325 Binney Street), mitigating climate-related risk in our asset base, and investing in and providing essential infrastructure for sustainable agrifoodtech companies; continuing strong progress toward our 2025 environmental impact goals, including further reducing carbon emissions; and catalyzing the health, wellness, safety, and productivity of our employees and tenants, local communities, and the world at large through the built environment and our social responsibility initiatives.

 

Acquisitions:
June 30, 2021
(Dollars in thousands)
											Square Footage
											Acquisitions With Development/Redevelopment Opportunities(1)
Property		Submarket/Market		Date of Purchase		Number of Properties		Operating Occupancy			Future Development		Active Development/ Redevelopment		Operating With Future Development/ Redevelopment				Operating(2)		Operating			Total		Purchase Price
Completed in 1Q21						25		94%			374,426		849,411		431,066				1,353,247		80,032			3,088,182		$  1,873,750
Completed in 2Q21:
550 Arsenal Street		Cambridge/Inner Suburbs/   Greater Boston		4/21/21		1		98%			775,000		—		260,867				—		—			775,000	(3)	130,000
One Investors Way		Route 128/Greater Boston		4/6/21		1		100%			350,000		—		—				240,000	(4)	—			590,000		105,000
1501-1599 Industrial Road		Greater Stanford/San    Francisco Bay Area		6/22/21		6		88%			—		—		103,063				—		—			103,063		112,000
2475 Hanover Street		Greater Stanford/San    Francisco Bay Area		4/28/21		1		100%			—		—		83,980				—		—			83,980		105,000
6260, 6290, 6310, 6340, and    6350 Sequence Drive		Sorrento Mesa/San Diego		6/10/21		5		100%			887,000		—		487,023				—		—			887,000	(3)	298,476
9601, 9605, 9609, 9613, and   9615 Medical Center Drive		Rockville/Maryland		5/12/21		5		100%			258,000		94,256		—				595,381		—			947,637		80,382
Other		Various		Various		5		77%			1,863,280		37,267		205,983				49,839		—			2,156,369		247,597
						24		96%			4,133,280		131,523		1,140,916				885,220		—			5,543,049		1,078,455
Completed in July 2021:
Other		Various		Various		13		91%			—		—		496,070				335,825		—			831,895		387,941
Pending acquisitions:
Charles Park		Cambridge/Greater Boston		December 2021		2		N/A			TBD(5)		400,000		—				—		—			400,000		815,000
Mercer Mega Block		Lake Union/Seattle		2H21(6)		—		N/A			800,000		—		—				—		—			800,000		143,500
						2					800,000		400,000		—				—		—			1,200,000		958,500
						64					5,307,706		1,380,934		2,068,052				2,574,292		80,032			10,663,126		4,298,646
Other future acquisitions																										661,354
2021 acquisitions																										$ 4,960,000
2021 guidance range																			$4,460,000 – $5,460,000

(1)	We expect to provide total estimated costs and related yields for development and redevelopment projects in the future, subsequent to the commencement of construction. Refer to "New Class A development and redevelopment properties: current projects" in our Supplemental Information for additional details on active development and redevelopment projects.
(2)	Represents the operating component of our value-creation acquisitions that is not expected to undergo development or redevelopment.
(3)	Represents total square footage upon completion of development or redevelopment of a new Class A property. Square footage presented includes RSF of buildings currently in operations with future development or redevelopment opportunities. We intend to demolish and develop or redevelop the existing properties upon expiration of the existing in-place leases. Refer to "Definitions and reconciliations" of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.
(4)	Upon acquisition of this property, we entered into a 12-year lease with Moderna, Inc.
(5)	We expect to pursue additional entitlement opportunities for future development of additional office/laboratory space.
(6)	We continue to diligently work through various long-lead-time due diligence items. We are working toward completion of all due diligence items as soon as possible.

 

Dispositions and Sales of Partial Interest
June 30, 2021
(Dollars in thousands)
													Capitalization Rate (Cash Basis)(1)									Sales Price per RSF			Consideration in Excess of Book Value(2)
Property		Submarket/Market		Date of Sale		Interest Sold		RSF		Capitalization Rate(1)						Sales Price
Completed through July 26, 2021:
213 East Grand Avenue		South San Francisco/    San Francisco Bay Area		4/22/21		70%		300,930		4.5 %			4.0 %			$	301,000					$	1,429		$	103,679
400 Dexter Avenue North		Lake Union/Seattle		7/23/21		70%		290,111		4.1 %			4.2 %			254,814						$	1,255		$	95,467
Land		Other/San Diego		3/12/21		100%		185,000		N/A			N/A			22,900						N/A				(3)
																$	578,714
Pending dispositions or sales of partial interest:
Pending(4)		Various		TBD		TBD										$285,000 – $385,000						TBD			TBD
2021 guidance range																$1,670,000 – $2,170,000

(1)	Capitalization rates are calculated based upon net operating income and net operating income (cash basis) annualized for the quarter preceding the date on which the property is sold.
(2)	We retained control over the newly formed real estate joint venture and therefore continued to consolidate this property. We accounted for the difference between the consideration received and the book value of the interest sold as an equity transaction, with no gain or loss recognized in earnings.
(3)	During the three months ended March 31, 2021, we recognized $2.8 million of gains on sales of real estate related to the completion of two real estate dispositions.
(4)	Represents transactions in various stages of completion ranging from receipt of offers to signed purchase and sale agreements.

 

Guidance

June 30, 2021

(Dollars in millions, except per share amounts)

On June 14, 2021, we issued a current report on Form 8-K providing updates to key 2021 guidance items in connection with our public offering of common stock. The following updated guidance is based on our current view of existing market conditions and assumptions for the year ending December 31, 2021. Our updated guidance does not reflect any significant changes from June 14, 2021, except as noted in the summary of key changes in guidance tables below. Also, refer to our discussion of "forward-looking statements" on page 7 of this Earnings Press Release for additional details.

 

		2021 Guidance						2021 Guidance
Summary of Key Changes in Guidance		As of 7/26/21		As of 6/14/21		Summary of Key Changes in Guidance		As of 7/26/21		As of 6/14/21
EPS, FFO per share, and FFO per share, as adjusted		See updates below				Fixed-charge coverage ratio – 4Q21 annualized		Greater than or equal to 5.0x		Greater than or equal to 4.8x
Same property net operating income increase		2.0% to 4.0%		1.7% to 3.7%
Same property net operating income increase (cash basis)		4.7% to 6.7%		4.3% to 6.3%

 

Projected 2021 Earnings per Share and Funds From Operations per Share Attributable to Alexandria's Common Stockholders – Diluted
		As of 7/26/21				As of 6/14/21
Earnings per share(1)		$3.46 to $3.54				$1.60 to $1.70
Depreciation and amortization of real estate assets			5.50				5.50
Gain on sales of real estate			(0.02)				(0.02)
Impairment of real estate – rental properties			0.05				0.04
Allocation to unvested restricted stock awards			(0.04)				(0.03)
Funds from operations per share(2)		$8.95 to $9.03				$7.09 to $7.19
Unrealized (gains) losses on non-real estate investments			(1.39)				0.34
Realized gains on non-real estate investments(3)			(0.41)				(0.17)
Impairment of real estate			0.02				—
Loss on early extinguishment of debt			0.47				0.49
Allocation to unvested restricted stock awards			0.01				(0.01)
Other			0.06				(0.04)
Funds from operations per share, as adjusted(2)		$7.71 to $7.79				$7.70 to $7.80
Midpoint		$7.75				$7.75

 

Key Assumptions		Low				High
Occupancy percentage in North America as of December 31, 2021		94.3%				94.9%
Lease renewals and re-leasing of space:
Rental rate increases		31.0%				34.0%
Rental rate increases (cash basis)		18.0%				21.0%
Same property performance:
Net operating income increase		2.0%				4.0%
Net operating income increase (cash basis)		4.7%				6.7%
Straight-line rent revenue		$	119			$	129
General and administrative expenses		$	146			$	151
Capitalization of interest		$	172			$	182
Interest expense		$	128			$	138

 

Key Credit Metrics		2021 Guidance
Net debt and preferred stock to Adjusted EBITDA – 4Q21 annualized		Less than or equal to 5.2x
Fixed-charge coverage ratio – 4Q21 annualized		Greater than or equal to 5.0x

 

Key Sources and Uses of Capital		Range						Midpoint			Certain Completed Items
Sources of capital:
Net cash provided by operating activities after dividends		$	210		$	250		$	230
Incremental debt		1,215			875				1,045
2020 debt capital proceeds held in cash		150			250				200
Real estate dispositions and partial interest sales (refer to page 5)		1,670			2,170				1,920		$	579
Common equity		2,975			3,975				3,475		$	3,048	(4)
Total sources of capital		$	6,220		$	7,520		$	6,870
Uses of capital:
Construction		$	1,760		$	2,060		$	1,910
Acquisitions		4,460			5,460				4,960		$	3,340
Total uses of capital		$	6,220		$	7,520		$	6,870
Incremental debt (included above):
Issuance of unsecured senior notes payable		$	1,750		$	1,750		$	1,750		$	1,750
Principal repayments of unsecured senior notes payable		(650)			(650)				(650)		$	(650)
Unsecured senior line of credit, commercial paper, and other		115			(225)				(55)
Incremental debt		$	1,215		$	875		$	1,045

(1)	Excludes unrealized gains or losses after June 30, 2021, that are required to be recognized in earnings and are excluded from funds from operations per share, as adjusted.
(2)	Refer to "Funds from operations and funds from operations, as adjusted, attributable to Alexandria's common stockholders" in "Definitions and reconciliations" of our Supplemental Information for additional details.
(3)	Refer to "Funds from operations and funds from operations per share" of this Earnings Press Release for additional details.
(4)	Refer to "Key capital events" on page 3 of this Earnings Press Release for additional details on our June 2021 public offering of common stock. During the six months ended June 30, 2021, we issued 13.8 million shares of common stock and received net proceeds of $2.3 billion. We expect to issue 4.6 million shares in 2H21 to settle our remaining outstanding forward equity sales agreements and receive net proceeds of approximately $778.4 million.

Earnings Call Information and About the Company
June 30, 2021

We will host a conference call on Tuesday, July 27, 2021, at 3:00 p.m. Eastern Time ("ET")/noon Pacific Time ("PT"), which is open to the general public, to discuss our financial and operating results for the second quarter ended June 30, 2021. To participate in this conference call, dial (833) 366-1125 or (412) 902-6738 shortly before 3:00 p.m. ET/noon PT and ask the operator to join the call for Alexandria Real Estate Equities, Inc. The audio webcast can be accessed at www.are.com in the "For Investors" section. A replay of the call will be available for a limited time from 5:00 p.m. ET/2:00 p.m. PT on Tuesday, July 27, 2021. The replay number is (877) 344-7529 or (412) 317-0088, and the access code is 10156073.

Additionally, a copy of this Earnings Press Release and Supplemental Information for the second quarter ended June 30, 2021, is available in the "For Investors" section of our website at www.are.com or by following this link: http://www.are.com/fs/2021q2.pdf.

For any questions, please contact Joel S. Marcus, executive chairman and founder; Stephen A. Richardson, co-chief executive officer; Peter M. Moglia, co-chief executive officer and co-chief investment officer; Dean A. Shigenaga, president and chief financial officer; or Paula Schwartz, managing director of Rx Communications Group, at (917) 322-2216; or Sara M. Kabakoff, vice president – communications, at (626) 578-0777.

About the Company

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500^® urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, agtech, and technology campuses in AAA innovation cluster locations, with a total market capitalization of $36.3 billion as of June 30, 2021, and an asset base in North America of 58.1 million square feet ("SF"). The asset base in North America includes 36.7 million RSF of operating properties and 3.4 million RSF of Class A properties undergoing construction, 7.7 million RSF of near-term and intermediate-term development and redevelopment projects, and 10.3 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

***********

This document includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2021 earnings per share attributable to Alexandria's common stockholders – diluted, 2021 funds from operations per share attributable to Alexandria's common stockholders – diluted, net operating income, and our projected sources and uses of capital. You can identify the forward-looking statements by their use of forward-looking words, such as "forecast," "guidance," "goals," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," "targets," or "will," or the negative of those words or similar words. These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. There can be no assurance that actual results will not be materially higher or lower than these expectations. These statements are subject to risks, uncertainties, assumptions, and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets (including the impact of the ongoing COVID-19 pandemic), our failure to successfully place into service and lease any properties undergoing development or redevelopment and our existing space held for future development or redevelopment (including new properties acquired for that purpose), our failure to successfully operate or lease acquired properties, decreased rental rates, increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by tenants, adverse general and local economic conditions, an unfavorable capital market environment, decreased leasing activity or lease renewals, failure to obtain LEED and other healthy building certifications and efficiencies, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission ("SEC"). Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this Earnings Press Release and Supplemental Information, and unless otherwise stated, we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

For additional discussion of the risks and other potential impacts posed by the outbreak of the COVID-19 pandemic and uncertainties we, our tenants, and the global and national economies face as a result, see the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our annual report on Form 10-K filed with the SEC on February 1, 2021.

Alexandria^®, Lighthouse Design^® logo, Building the Future of Life-Changing Innovation™, That's What's in Our DNA^®, Labspace^®, Alexandria Center^®, Alexandria Technology Square^®, Alexandria Technology Center^®, Alexandria Innovation Center^®, and Alexandria Summit^® are copyrights and trademarks of Alexandria Real Estate Equities, Inc. All other company names, trademarks, and logos referenced herein are the property of their respective owners.

 

Consolidated Statements of Operations
June 30, 2021
(Dollars in thousands, except per share amounts)
		Three Months Ended															Six Months Ended
		6/30/21			3/31/21			12/31/20			9/30/20			6/30/20			6/30/21			6/30/20
Revenues:
Income from rentals		$	508,371		$	478,695		$	461,335		$	543,412		$	435,856		$	987,066		$	873,461
Other income		1,248			1,154			2,385			1,630			1,100			2,402			3,414
Total revenues		509,619			479,849			463,720			545,042			436,956			989,468			876,875
Expenses:
Rental operations		143,955			137,888			136,767			140,443			123,911			281,843			253,014
General and administrative		37,880			33,996			32,690			36,913			31,775			71,876			63,738
Interest		35,158			36,467			37,538			43,318			45,014			71,625			90,753
Depreciation and amortization		190,052			180,913			177,750			176,831			168,027			370,965			343,523
Impairment of real estate		4,926			5,129			25,177			7,680			13,218			10,055			15,221
Loss on early extinguishment of debt		—			67,253			7,898			52,770			—			67,253			—
Total expenses		411,971			461,646			417,820			457,955			381,945			873,617			766,249
Equity in earnings of unconsolidated real estate joint ventures		2,609			3,537			3,593			3,778			3,893			6,146			777
Investment income		304,263			1,014			255,137			3,348			184,657			305,277			162,836
Gain on sales of real estate		—			2,779			152,503			1,586			—			2,779			—
Net income		404,520			25,533			457,133			95,799			243,561			430,053			274,239
Net income attributable to noncontrolling interests		(19,436)			(17,412)			(15,649)			(14,743)			(13,907)			(36,848)			(25,820)
Net income attributable to Alexandria Real Estate Equities, Inc.'s stockholders		385,084			8,121			441,484			81,056			229,654			393,205			248,419
Net income attributable to unvested restricted stock awards		(4,521)			(2,014)			(5,561)			(1,730)			(3,054)			(4,663)			(3,574)
Net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders		$	380,563		$	6,107		$	435,923		$	79,326		$	226,600		$	388,542		$	244,845
Net income per share attributable to Alexandria Real Estate Equities, Inc.'s common stockholders:
Basic		$	2.61		$	0.04		$	3.26		$	0.64		$	1.82		$	2.74		$	1.99
Diluted		$	2.61		$	0.04		$	3.26		$	0.63		$	1.82		$	2.74		$	1.99
Weighted-average shares of common stock outstanding:
Basic		145,825			137,319			133,688			124,901			124,333			141,596			122,883
Diluted		146,058			137,688			133,827			125,828			124,448			141,896			123,117
Dividends declared per share of common stock		$	1.12		$	1.09		$	1.09		$	1.06		$	1.06		$	2.21		$	2.09

 

Consolidated Balance Sheets
June 30, 2021
(In thousands)
		6/30/21			3/31/21			12/31/20			9/30/20			6/30/20
Assets
Investments in real estate		$	21,692,385		$	20,253,418		$	18,092,372		$	17,600,648		$	16,281,125
Investments in unconsolidated real estate joint ventures		323,622			325,928			332,349			330,792			326,858
Cash and cash equivalents		323,876			492,184			568,532			446,255			206,860
Restricted cash		33,697			42,219			29,173			38,788			34,680
Tenant receivables		6,710			7,556			7,333			7,641			7,208
Deferred rent		781,600			751,967			722,751			719,552			688,749
Deferred leasing costs		321,005			294,328			272,673			266,440			274,483
Investments		1,999,283			1,641,811			1,611,114			1,330,945			1,318,465
Other assets		1,536,672			1,424,935			1,191,581			1,169,610			930,680
Total assets		$	27,018,850		$	25,234,346		$	22,827,878		$	21,910,671		$	20,069,108
Liabilities, Noncontrolling Interests, and Equity
Secured notes payable		$	227,984		$	229,406		$	230,925		$	342,363		$	344,784
Unsecured senior notes payable		8,313,025			8,311,512			7,232,370			7,230,819			6,738,486
Unsecured senior line of credit and commercial paper		299,990			—			99,991			249,989			440,000
Accounts payable, accrued expenses, and other liabilities		1,825,387			1,750,687			1,669,832			1,609,340			1,343,181
Dividends payable		170,647			160,779			150,982			143,040			133,681
Total liabilities		10,837,033			10,452,384			9,384,100			9,575,551			9,000,132
Commitments and contingencies
Redeemable noncontrolling interests		11,567			11,454			11,342			11,232			12,122
Alexandria Real Estate Equities, Inc.'s stockholders' equity:
Common stock		1,507			1,457			1,367			1,333			1,246
Additional paid-in capital		14,194,023			12,994,748			11,730,970			10,711,119			9,443,274
Accumulated other comprehensive loss		(4,508)			(5,799)			(6,625)			(10,638)			(13,080)
Alexandria Real Estate Equities, Inc.'s stockholders' equity		14,191,022			12,990,406			11,725,712			10,701,814			9,431,440
Noncontrolling interests		1,979,228			1,780,102			1,706,724			1,622,074			1,625,414
Total equity		16,170,250			14,770,508			13,432,436			12,323,888			11,056,854
Total liabilities, noncontrolling interests, and equity		$	27,018,850		$	25,234,346		$	22,827,878		$	21,910,671		$	20,069,108

 

Funds From Operations and Funds From Operations per Share
June 30, 2021
(In thousands)

     The following table presents a reconciliation of net income (loss) attributable to Alexandria's common stockholders, the most directly comparable financial measure presented in accordance with U.S. generally accepted accounting principles ("GAAP"), including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations attributable to Alexandria's common stockholders – diluted, and funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted, for the periods below:

		Three Months Ended															Six Months Ended
		6/30/21			3/31/21			12/31/20			9/30/20			6/30/20			6/30/21			6/30/20
Net income attributable to Alexandria's common stockholders		$	380,563		$	6,107		$	435,923		$	79,326		$	226,600		$	388,542		$	244,845
Depreciation and amortization of real estate assets		186,498			177,720			173,392			173,622			165,040			364,218			337,668
Noncontrolling share of depreciation and amortization from consolidated real estate JVs		(16,301)			(15,443)			(15,032)			(15,256)			(15,775)			(31,744)			(31,645)
Our share of depreciation and amortization from unconsolidated real estate JVs		4,135			3,076			2,976			2,936			2,858			7,211			5,501
Gain on sales of real estate		—			(2,779)			(152,503)			(1,586)			—			(2,779)			—
Impairment of real estate – rental properties		1,754			5,129			25,177			7,680			—			6,883			7,644
Allocation to unvested restricted stock awards		(2,191)			(201)			(420)			(1,261)			(2,228)			(4,427)			(4,531)
Funds from operations attributable to Alexandria's common stockholders – diluted(1)		554,458			173,609			469,513			245,461			376,495			727,904			559,482
Unrealized (gains) losses on non-real estate investments		(244,031)			46,251			(233,538)			14,013			(171,652)			(197,780)			(154,508)
Realized gains on non-real estate investments		(34,773)		(2)	(22,919)			—			—			—			(57,692)			—
Impairment of non-real estate investments		—			—			—			—			4,702			—			24,482
Impairment of real estate		3,172			—			—			—			13,218			3,172			15,221
Loss on early extinguishment of debt		—			67,253			7,898			52,770			—			67,253			—
Termination fee		—			—			—			(86,179)			—			—			—
Acceleration of stock compensation expense due to executive officer resignation		—			—			—			4,499			—			—			—
Allocation to unvested restricted stock awards		3,428			(1,208)			2,774			179			2,251			2,382			1,711
Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted		$	282,254		$	262,986		$	246,647		$	230,743		$	225,014		$	545,239		$	446,388

(1)	Calculated in accordance with standards established by the Nareit Board of Governors. Refer to "Funds from operations and funds from operations, as adjusted, attributable to Alexandria's common stockholders" in the "Definitions and reconciliations" of our Supplemental Information for additional details.
(2)	Represents realized gains related to the sales of our investments in two publicly traded biotechnology companies.

Funds From Operations and Funds From Operations per Share (continued)
June 30, 2021
(In thousands, except per share amounts)

     The following table presents a reconciliation of net income (loss) per share attributable to Alexandria's common stockholders, the most directly comparable financial measure presented in accordance with GAAP, including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations per share attributable to Alexandria's common stockholders – diluted, and funds from operations per share attributable to Alexandria's common stockholders – diluted, as adjusted, for the periods below. Per share amounts may not add due to rounding.

		Three Months Ended															Six Months Ended
		6/30/21			3/31/21			12/31/20			9/30/20			6/30/20			6/30/21			6/30/20
Net income per share attributable to Alexandria's common stockholders – diluted		$	2.61		$	0.04		$	3.26		$	0.63		$	1.82		$	2.74		$	1.99
Depreciation and amortization of real estate assets		1.19			1.20			1.21			1.28			1.22			2.39			2.53
Gain on sales of real estate		—			(0.02)			(1.14)			(0.01)			—			(0.02)			—
Impairment of real estate – rental properties		0.01			0.04			0.19			0.06			—			0.05			0.06
Allocation to unvested restricted stock awards		(0.01)			—			(0.01)			(0.01)			(0.01)			(0.03)			(0.04)
Funds from operations per share attributable to Alexandria's common stockholders – diluted		3.80			1.26			3.51			1.95			3.03			5.13			4.54
Unrealized (gains) losses on non-real estate investments		(1.67)			0.34			(1.75)			0.11			(1.38)			(1.39)			(1.25)
Realized gains on non-real estate investments		(0.24)			(0.17)			—			—			—			(0.41)			—
Impairment of non-real estate investments		—			—			—			—			0.04			—			0.20
Impairment of real estate		0.02			—			—			—			0.11			0.02			0.12
Loss on early extinguishment of debt		—			0.49			0.06			0.42			—			0.47			—
Termination fee		—			—			—			(0.69)			—			—			—
Acceleration of stock compensation expense due to executive officer resignation		—			—			—			0.04			—			—			—
Allocation to unvested restricted stock awards		0.02			(0.01)			0.02			—			0.01			0.02			0.02
Funds from operations per share attributable to Alexandria's common stockholders – diluted, as adjusted		$	1.93		$	1.91		$	1.84		$	1.83		$	1.81		$	3.84		$	3.63
Weighted-average shares of common stock outstanding – diluted(1)		146,058			137,688			133,827			125,828			124,448			141,896			123,117

(1)	Refer to "Weighted-average shares of common stock outstanding – diluted" in the "Definitions and reconciliations" of our Supplemental Information for additional details.

 

View original content:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-at-the-vanguard-of-providing-high-quality-officelaboratory-space-to-meet-historic-high-demand-from-the-life-science-industry-reports-2q21-and-1h21-net-income-per-share--diluted-of-2-61-a-301341309.html

SOURCE Alexandria Real Estate Equities, Inc.